These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Bauwens D; Hantson P; Laterre PF; Michaux L; Latinne D; De Tourtchaninoff M; Cosnard G; Hernalsteen D Leuk Lymphoma; 2005 Nov; 46(11):1671-4. PubMed ID: 16236621 [TBL] [Abstract][Full Text] [Related]
3. Clinical side effects during peripheral blood progenitor cell infusion. Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813 [TBL] [Abstract][Full Text] [Related]
4. The impact of preapheresis white blood cell count on autologous peripheral blood stem cell collection efficiency and HSC infusion side effect rate. Sakashita AM; Kondo AT; Yokoyama APH; Lira SMC; Bub CB; Souza AM; Cipolletta ANF; Alvarez KC; Hamerschlak N; Kutner JM; Chiattone CS J Clin Apher; 2018 Jun; 33(3):331-341. PubMed ID: 29350425 [TBL] [Abstract][Full Text] [Related]
5. Neurotoxicity Associated With Dimethyl Sulfoxide Used in Allogeneic Stem Cell Transplantation. Ataseven E; Tüfekçi Ö; Yilmaz Ş; Güleryüz H; Ören H J Pediatr Hematol Oncol; 2017 Jul; 39(5):e297-e299. PubMed ID: 28121745 [TBL] [Abstract][Full Text] [Related]
6. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Zenhäusern R; Tobler A; Leoncini L; Hess OM; Ferrari P Ann Hematol; 2000 Sep; 79(9):523-6. PubMed ID: 11043425 [TBL] [Abstract][Full Text] [Related]
7. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components. Rowley S; MacLeod B; Heimfeld S; Holmberg L; Bensinger W Cytotherapy; 1999; 1(4):311-7. PubMed ID: 20440908 [TBL] [Abstract][Full Text] [Related]
8. Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease. Mueller LP; Theurich S; Christopeit M; Grothe W; Muetherig A; Weber T; Guenther S; Behre G Eur J Haematol; 2007 Jun; 78(6):527-31. PubMed ID: 17509106 [TBL] [Abstract][Full Text] [Related]
9. Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study. Mitrus I; Smagur A; Fidyk W; Czech M; Prokop M; Chwieduk A; Glowala-Kosinska M; Czerw T; Sobczyk-Kruszelnicka M; Mendrek W; Michalak K; Sadus-Wojciechowska M; Najda J; Holowiecki J; Giebel S Bone Marrow Transplant; 2018 Mar; 53(3):274-280. PubMed ID: 29269805 [TBL] [Abstract][Full Text] [Related]
10. Severe vasospastic angina with hemodynamic compromise related to the infusion of dimethyl sulfoxide (DMSO)-cryopreserved autologous peripheral blood stem cells. Bambace NM; Lachance S Ann Hematol; 2013 Nov; 92(11):1571-2. PubMed ID: 23580150 [No Abstract] [Full Text] [Related]
11. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Hoyt R; Szer J; Grigg A Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734 [TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight carbohydrate Pentaisomaltose may replace dimethyl sulfoxide as a safer cryoprotectant for cryopreservation of peripheral blood stem cells. Svalgaard JD; Haastrup EK; Reckzeh K; Holst B; Glovinski PV; Gørløv JS; Hansen MB; Moench KT; Clausen C; Fischer-Nielsen A Transfusion; 2016 May; 56(5):1088-95. PubMed ID: 26991781 [TBL] [Abstract][Full Text] [Related]
13. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079 [TBL] [Abstract][Full Text] [Related]
17. No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. Bakken AM; Bruserud O; Abrahamsen JF J Hematother Stem Cell Res; 2003 Jun; 12(3):351-8. PubMed ID: 12857376 [TBL] [Abstract][Full Text] [Related]
18. DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents? Marcacci G; Corazzelli G; Becchimanzi C; Arcamone M; Capobianco G; Russo F; Frigeri F; Pinto A Bone Marrow Transplant; 2009 Jul; 44(2):133-5. PubMed ID: 19182835 [No Abstract] [Full Text] [Related]
19. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Ozdemir E; Akgedik K; Akdogan S; Kansu E Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066 [TBL] [Abstract][Full Text] [Related]